Abstract
BackgroundIntravenous(IV)insulin infusion is the standard of care for treating diabetic ketoacidosis (DKA) worldwide. Subcutaneous (SC) insulin aspart could decrease the use of health care resources.Aim of StudyTo compare the cost-effectiveness...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have